Structure of the N-terminal Domain of the FOP (FGFR1OP) Protein and Implications for its Dimerization and Centrosomal Localization

Journal of Molecular Biology

Volumn 359, Issue 4, 2006, Pages 863-875

  Mikolajka, Aleksandra ^a   Yan, Xiumin ^a   Popowicz, Grzegorz M ^a   Smialowski, Pawel ^a   Nigg, Erich A ^a   Holak, Tad A ^a  

^a MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

Author keywords

centrosome; FGFR1; FOP; LisH domain; MPD

Indexed keywords

FIBROBLAST GROWTH FACTOR RECEPTOR 1; ONCOPROTEIN;

ALPHA HELIX; AMINO TERMINAL SEQUENCE; ARTICLE; CENTROSOME; CRYSTAL STRUCTURE; DIMERIZATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN LOCALIZATION; PROTEIN STRUCTURE;

EUKARYOTA;

EID: 33744796303     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2006.03.070     Document Type: Article

References (61)

1. Popovici C., Zhang B., Gregoire M.J., Jonveaux P., Lafage-Pochitaloff M., Birnbaum D., and Pebusque M.J. The t(6;8)(q27;p11) translocation in a stem cell myeloproliferative disorder fuses a novel gene, FOP, to fibroblast growth factor receptor 1. Blood 93 (1999) 1381-1389
2. Kobe B., and Deisenhofer J. The leucine-rich repeat: a versatile binding motif. Trends Biochem. Sci. 19 (1994) 415-421
3. Kajava A.V. Structural diversity of leucine-rich repeat proteins. J. Mol. Biol. 277 (1998) 519-527
4. von Mering C., Jensen L.J., Snel B., Hooper S.D., Krupp M., Foglierini M., et al. STRING: known and predicted protein-protein associations, integrated and transferred across organisms. Nucl. Acids Res. 33 (2005) D433-D437
5. Jensen L.J., Lagarde J., von Mering C., and Bork P. ArrayProspector: a web resource of functional associations inferred from microarray expression data. Nucl. Acids Res. 32 (2004) W445-W448
6. Zou X., Tsutsui T., Ray D., Blomquist J.F., Ichijo H., Ucker D.S., and Kiyokawa H. The cell cycle-regulatory CDC25A phosphatase inhibits apoptosis signal-regulating kinase 1. Mol. Cell. Biol. 21 (2001) 4818-4828
7. Vidwans S.J., Wong M.L., and O'Farrell P.H. Mitotic regulators govern progress through steps in the centrosome duplication cycle. J. Cell Biol. 147 (1999) 1371-1378
8. Duensing S., and Munger K. Human papillomavirus type 16 E7 oncoprotein can induce abnormal centrosome duplication through a mechanism independent of inactivation of retinoblastoma protein family members. J. Virol. 77 (2003) 12331-12335
9. Donaldson M.M., Tavares A.A., Hagan I.M., Nigg E.A., and Glover D.M. The mitotic roles of Polo-like kinase. J. Cell Sci. 114 (2001) 2357-2358
10. Macdonald D., Aguiar R.C., Mason P.J., Goldman J.M., and Cross N.C. A new myeloproliferative disorder associated with chromosomal translocations involving 8p11: a review. Leukemia 9 (1995) 1628-1630
11. Aguiar R.C., Macdonald D., Mason P.J., Cross N.C., and Goldman J.M. Myeloproliferative disorder associated with 8p11 translocations. Blood 86 (1995) 834-835
12. Popovici C., Adelaide J., Ollendorff V., Chaffanet M., Guasch G., Jacrot M., et al. Fibroblast growth factor receptor 1 is fused to FIM in stem-cell myeloproliferative disorder with t(8;13). Proc. Natl Acad. Sci. USA 95 (1998) 5712-5717
13. Reiter A., Sohal J., Kulkarni S., Chase A., Macdonald D.H., Aguiar R.C., et al. Consistent fusion of ZNF198 to the fibroblast growth factor receptor-1 in the t(8;13)(p11;q12) myeloproliferative syndrome. Blood 92 (1998) 1735-1742
14. Xiao S., Nalabolu S.R., Aster J.C., Ma J., Abruzzo L., Jaffe E.S., et al. FGFR1 is fused with a novel zinc-finger gene, ZNF198, in the t(8;13) leukaemia/lymphoma syndrome. Nature Genet. 18 (1998) 84-87
15. Guasch G., Mack G.J., Popovici C., Dastugue N., Birnbaum D., Rattner J.B., and Pebusque M.J. FGFR1 is fused to the centrosome-associated protein CEP110 in the 8p12 stem cell myeloproliferative disorder with t(8;9)(p12;q33). Blood 95 (2000) 1788-1796
16. Demiroglu A., Steer E.J., Heath C., Taylor K., Bentley M., Allen S.L., et al. The t(8;22) in chronic myeloid leukemia fuses BCR to FGFR1: transforming activity and specific inhibition of FGFR1 fusion proteins. Blood 98 (2001) 3778-3783
17. Fioretos T., Panagopoulos I., Lassen C., Swedin A., Billstrom R., Isaksson M., et al. Fusion of the BCR and the fibroblast growth factor receptor-1 (FGFR1) genes as a result of t(8;22)(p11;q11) in a myeloproliferative disorder: the first fusion gene involving BCR but not ABL. Genes Chromosomes Cancer 32 (2001) 302-310
18. Delaval B., Letard S., Lelievre H., Chevrier V., Daviet L., Dubreuil P., and Birnbaum D. Oncogenic tyrosine kinase of malignant hemopathy targets the centrosome. Cancer Res. 65 (2005) 7231-7240
19. Vizmanos J.L., Hernandez R., Vidal M.J., Larrayoz M.J., Odero M.D., Marin J., et al. Clinical variability of patients with the t(6;8)(q27;p12) and FGFR1OP-FGFR1 fusion: two further cases. Hematol. J. 5 (2004) 534-537
20. Xiao S., McCarthy J.G., Aster J.C., and Fletcher J.A. ZNF198-FGFR1 transforming activity depends on a novel proline-rich ZNF198 oligomerization domain. Blood 96 (2000) 699-704
21. Ollendorff V., Guasch G., Isnardon D., Galindo R., Birnbaum D., and Pebusque M.J. Characterization of FIM-FGFR1, the fusion product of the myeloproliferative disorder-associated t(8;13) translocation. J. Biol. Chem. 274 (1999) 26922-26930
22. Guasch G., Ollendorff V., Borg J.P., Birnbaum D., and Pebusque M.J. 8p12 stem cell myeloproliferative disorder: the FOP-fibroblast growth factor receptor 1 fusion protein of the t(6;8) translocation induces cell survival mediated by mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt/mTOR pathways. Mol. Cell. Biol. 21 (2001) 8129-8142
23. Foehr E.D., Raffioni S., Murray-Rust J., and Bradshaw R.A. The role of tyrosine residues in fibroblast growth factor receptor 1 signaling in PC12 cells. Systematic site-directed mutagenesis in the endodomain. J. Biol. Chem. 276 (2001) 37529-37536
24. Cross M.J., Lu L., Magnusson P., Nyqvist D., Holmqvist K., Welsh M., and Claesson-Welsh L. The Shb adaptor protein binds to tyrosine 766 in the FGFR-1 and regulates the Ras/MEK/MAPK pathway via FRS2 phosphorylation in endothelial cells. Mol. Biol. Cell. 13 (2002) 2881-2893
25. Chang F., Lee J.T., Navolanic P.M., Steelman L.S., Shelton J.G., Blalock W.L., et al. Involvement of PI3K/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: a target for cancer chemotherapy. Leukemia 17 (2003) 590-603
26. Browaeys-Poly E., Fafeur V., Vilain J.P., and Cailliau K. ERK2 is required for FGF1-induced JNK1 phosphorylation in Xenopus oocyte expressing FGF receptor 1. Biochim. Biophys. Acta 1743 (2005) 1-4
27. Cardone M.H., Roy N., Stennicke H.R., Salvesen G.S., Franke T.F., Stanbridge E., et al. Regulation of cell death protease caspase-9 by phosphorylation. Science 282 (1998) 1318-1321
28. Andersen J.S., Wilkinson C.J., Mayor T., Mortensen P., Nigg E.A., and Mann M. Proteomic characterization of the human centrosome by protein correlation profiling. Nature 426 (2003) 570-574
29. Yan X., Habedanck R., and Nigg E.A. A Complex of two centrosomal proteins, CAP350 and FOP, cooperates with EB1 in MT anchoring. Mol. Biol. Cell 17 (2005) 634-644
30. Rieder C.L., Faruki S., and Khodjakov A. The centrosome in vertebrates: more than a microtubule-organizing center. Trends. Cell. Biol. 11 (2001) 413-419
31. Ou Y., and Rattner J.B. The centrosome in higher organisms: structure, composition, and duplication. Int. Rev. Cytol. 238 (2004) 119-182
32. Stearns T. Centrosome duplication. a centriolar pas de deux. Cell 105 (2001) 417-420
33. Nigg E.A. Centrosome aberrations: cause or consequence of cancer progression?. Nature Rev. Cancer 2 (2002) 815-825
34. Metge B., Ofori-Acquah S., Stevens T., and Balczon R. Stat3 activity is required for centrosome duplication in Chinese hamster ovary cells. J. Biol. Chem. 279 (2004) 41801-41806
35. Arlot-Bonnemains Y., and Prigent C. Cell cycle. A trigger for centrosome duplication. Science 295 (2002) 455-456
36. Delaval B., Lelievre H., and Birnbaum D. Myeloproliferative disorders: the centrosome connection. Leukemia 19 (2005) 1739-1744
37. Camilleri C., Azimzadeh J., Pastuglia M., Bellini C., Grandjean O., and Bouchez D. The Arabidopsis TONNEAU2 gene encodes a putative novel protein phosphatase 2A regulatory subunit essential for the control of the cortical cytoskeleton. Plant Cell 14 (2002) 833-845
38. Emes R.D., and Ponting C.P. A new sequence motif linking lissencephaly. Treacher Collins and oral-facial-digital type 1 syndromes, microtubule dynamics and cell migration. Hum. Mol. Genet. 10 (2001) 2813-2820
39. Umeda M., Nishitani H., and Nishimoto T. A novel nuclear protein, Twa1, and Muskelin comprise a complex with RanBPM. Gene 303 (2003) 47-54
40. Pancoast M., Dobyns W., and Golden J.A. Interneuron deficits in patients with the Miller-Dieker syndrome. Acta Neuropathol. (Berl) 109 (2005) 400-404
41. Dixon J., Ellis I., Bottani A., Temple K., and Dixon M.J. Identification of mutations in TCOF1: use of molecular analysis in the pre- and postnatal diagnosis of Treacher Collins syndrome. Am. J. Med. Genet. A 127 (2004) 244-248
42. Ferrante M.I., Giorgio G., Feather S.A., Bulfone A., Wright V., Ghiani M., et al. Identification of the gene for oral-facial-digital type I syndrome. Am. J. Hum. Genet. 68 (2001) 569-576
43. Bassi M.T., Ramesar R.S., Caciotti B., Winship I.M., De Grandi A., Riboni M., et al. X-linked late-onset sensorineural deafness caused by a deletion involving OA1 and a novel gene containing WD-40 repeats. Am. J. Hum. Genet. 64 (1999) 1604-1616
44. Zhang O., and Forman-Kay J.D. Structural characterization of folded and unfolded states of an SH3 domain in equilibrium in aqueous buffer. Biochemistry 34 (1995) 6784-6794
45. Rehm T., Huber R., and Holak T.A. Application of NMR in structural proteomics: screening for proteins amenable to structural analysis. Structure (Camb) 10 (2002) 1613-1618
46. Holm L., and Sander C. Protein structure comparison by alignment of distance matrices. J. Mol. Biol. 233 (1993) 123-138
47. Gibrat J.F., Madej T., and Bryant S.H. Surprising similarities in structure comparison. Curr. Opin. Struct. Biol. 6 (1993) 377-385
48. Kim M.H., Cooper D.R., Oleksy A., Devedjiev Y., Derewenda U., Reiner O., et al. The structure of the N-terminal domain of the product of the lissencephaly gene Lis1 and its functional implications. Structure (Camb) 12 (2004) 987-998
49. Mateja A., Cierpicki T., Paduch M., Derewenda Z.S., and Otlewski J. The dimerization mechanism of LIS1 and its implication for proteins containing the LisH motif. J. Mol. Biol 357 (2006) 621-631
50. Romio L., Fry A.M., Winyard P.J., Malcolm S., Woolf A.S., and Feather S.A. OFD1 is a centrosomal/basal body protein expressed during mesenchymal-epithelial transition in human nephrogenesis. J. Am. Soc. Nephrol. 15 (2004) 2556-2568
51. Landschulz W.H., Johnson P.F., and McKnight S.L. The leucine zipper: a hypothetical structure common to a new class of DNA binding proteins. Science 240 (1988) 1759-1764
52. Weber T., Baumgartner R., Renner C., Marahiel M.A., and Holak T.A. Solution structure of PCP, a prototype for the peptidyl carrier domains of modular peptide synthetases. Struct. Fold. Des. 8 (2000) 407-418
53. Muchmore D.C., McIntosh L.P., Russell C.B., Anderson D.E., and Dahlquist F.W. Expression and nitrogen-15 labeling of proteins for proton and nitrogen-15 nuclear magnetic resonance. Methods Enzymol. 177 (1989) 44-73
54. Powell H.R. The Rossmann Fourier autoindexing algorithm in MOSFLM. Acta Crystallog. sect. D 55 (1999) 1690-1695
55. Kabsch W. Automatic processing of rotation diffraction data from crystals of initially unknown symmetry and cell constants. J. Appl. Crystallog. 26 (1993) 795-800
56. Collaborative Computational Project, Number 4. The CCP4 suite: programs for protein crystallography. Acta Crystallog. sect. D 50 (1994) 760-763
57. Adams P.D., Gopal K., Grosse-Kunstleve R.W., Hung L.W., Ioerger T.R., McCoy A.J., et al. Recent developments in the PHENIX software for automated crystallographic structure determination. J. Synchrotron Radiat. 11 (2004) 53-55
58. Bricogne G., Vonrhein C., Flensburg C., Schiltz M., and Paciorek W. Generation, representation and flow of phase information in structure determination: recent developments in and around SHARP 2.0. Acta Crystallog. sect. D 59 (2003) 2023-2030
59. Perrakis A., Morris R., and Lamzin V.S. Automated protein model building combined with iterative structure refinement. Nature Struct. Biol. 6 (1999) 458-463
60. McRee D.E. XtalView/Xfit-A versatile program for manipulating atomic coordinates and electron density. J. Struct. Biol. 125 (1999) 156-165
61. Meraldi P., and Nigg E.A. The centrosome cycle. FEBS Letters 521 (2002) 9-13